(R)-5-((9H-fluoren-9-yl)methoxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid, 98%, 5g

4-Acetyl-3-fluorobenzonitrile, 97%, 10g

5'-(4-Carboxy-3-methylphenyl)-3,3''-dimethyl-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid, 98%, 250mg

Matraz de fondo redondo con junta esmerilada estándar 100 ml NS 19/26

(R)-4-(TERT-BUTYL)-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

3-Amino-6-chloropyridine-2-carbonitrile, 97.0%, 10g

N-(4-Chloro-3-methylphenyl)-4-methylbenzenesulfonamide, 95%, 100mg

3,3,3-Trifluoro-2-hydroxy-2-methylpropionic Acid>97.0%(T)1g

tert-Butyl (6-methylpyridin-3-yl)carbamate, 95.0%, 100mg

PTio, 98%, 1g

8-benzyl-7,8-dihydrotetrazolo[1,5-a]pyrazin-6(5H)-one, 250mg

1-(2-ethoxybenzoyl)piperazine, 95.0%, 2g

3-Amino-4-ethoxybenzoic acid, 97.0%, 5g